Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metastatic colorectal cancer
| Autor: | Jamal Zekri, Mohammed Abbas Baghdadi, Refaei Belal Ibrahim, Abdelrazak Meliti, Turki M Sobahy |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | ecancermedicalscience. 16 |
| ISSN: | 1754-6605 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|